Russell Investments Group, Ltd.

Position in TRDA — Entrada Therapeutics, Inc.

CIK 1692234 Seattle, WA

Position in TRDA

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$172,591

+$25,785 QoQ

Shares Held

23,450

+101.6% QoQ

Ownership

0.060%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#77

of 128 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,494,413,888 across 308 Biotechnology names. TRDA ranks #191 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	336,990	$167,393,033
2	REGN	Regeneron Pharmaceuticals, Inc.	230,151	$143,508,345
3	RPRX	Royalty Pharma plc	1,694,250	$94,996,587
4	INCY	Incyte Corp	425,616	$48,247,822
5	ALNY	Alnylam Pharmaceuticals, Inc.	158,228	$47,631,369
6	BMRN	Biomarin Pharmaceutical Inc	783,148	$44,811,725
7	LGND	Ligand Pharmaceuticals Inc	120,304	$38,026,888
8	PTCT	Ptc Therapeutics, Inc.	418,025	$34,098,295

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$172,591	23,450	+101.6%	Shares	Other	2026-08-06
2026-03-31	$146,806	11,633	+0.5%	Shares	Other	2026-05-08
2025-12-31	$118,948	11,571	+31.4%	Shares	Defined	2026-02-17
2025-09-30	$51,085	8,808	+72.7%	Shares	Other	2025-11-13
2025-06-30	$34,277	5,101	-1.0%	Shares	Other	2025-08-13
2025-03-31	$46,590	5,154	+6.9%	Shares	Other	2025-05-13
2024-12-31	$83,335	4,820	+53455.6%	Shares	Other	2025-02-13
2024-09-30	$143	9	-99.6%	Shares	Defined	2024-11-13
2024-06-30	$29,354	2,060	+22788.9%	Shares	Defined	2024-08-08
2024-03-31	$127	9	0.0%	Shares	Defined	2024-05-08
2023-12-31	$135	9	0.0%	Shares	Defined	2024-02-05
2023-09-30	$142	9	-99.9%	Shares	Defined	2023-11-13
2023-06-30	$102,240	6,753	—	Shares	Defined	2023-08-10
No filing history on record for this holder in this stock.